Profile | GDS4284 / 226179_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 6553.67 | 95 |
GSM687648 | Patient 402 control | 11082 | 97 |
GSM687653 | Patient 403 control | 2555.94 | 87 |
GSM687658 | Patient 404 control | 5763.25 | 94 |
GSM687663 | Patient 411 control | 8795.26 | 97 |
GSM687668 | Patient 422 control | 8321.56 | 96 |
GSM687673 | Patient 424 control | 18987.1 | 99 |
GSM687678 | Patient 425 control | 6623.2 | 95 |
GSM687683 | Patient 427 control | 8036.45 | 96 |
GSM687688 | Patient 428 control | 2624.04 | 87 |
GSM687695 | Patient 441 control | 74878.1 | 99 |
GSM687699 | Patient 443 control | 10532.2 | 97 |
GSM687704 | Patient 444 control | 4290.83 | 92 |
GSM687707 | Patient 448 control | 5736.26 | 94 |
GSM687712 | Patient 449 control | 6837.3 | 95 |
GSM687719 | Patient 450 control | 16109.1 | 98 |
GSM687724 | Patient 451 control | 17072.6 | 98 |
GSM687728 | Patient 452 control | 18063.6 | 98 |
GSM687646 | Patient 401 treated 24h | 4029.14 | 92 |
GSM687649 | Patient 402 treated 24h | 10413.4 | 97 |
GSM687665 | Patient 411 treated 24h | 8471.42 | 96 |
GSM687651 | Patient 402 treated 4 weeks | 11326.1 | 98 |
GSM687667 | Patient 411 treated 4 weeks | 5707.79 | 94 |
GSM687670 | Patient 422 treated 24h | 7664.16 | 96 |
GSM687671 | Patient 422 treated 4 weeks | 8353.34 | 96 |
GSM687654 | Patient 403 treated 24h | 2786.98 | 88 |
GSM687675 | Patient 424 treated 24h | 20715.6 | 99 |
GSM687685 | Patient 427 treated 24h | 9850.96 | 97 |
GSM687656 | Patient 403 treated 4 weeks | 3899.31 | 91 |
GSM687677 | Patient 424 treated 4 weeks | 6907.69 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 2844.36 | 88 |
GSM687692 | Patient 428 treated 4h | 4358.22 | 92 |
GSM687716 | Patient 449 treated 4h | 4447.16 | 92 |
GSM687722 | Patient 450 treated 4h | 16633.4 | 98 |
GSM687680 | Patient 425 treated 24h | 7461.36 | 96 |
GSM687690 | Patient 428 treated 24h | 5237.67 | 93 |
GSM687700 | Patient 443 treated 24h | 29582.6 | 99 |
GSM687705 | Patient 444 treated 24h | 7171.66 | 95 |
GSM687714 | Patient 449 treated 24h | 8224.19 | 96 |
GSM687721 | Patient 450 treated 24h | 34829.6 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 5899.59 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 5016.61 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 8502.89 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 4347.41 | 92 |
GSM687723 | Patient 450 treated 4 weeks | 12666.3 | 98 |
GSM687661 | Patient 404 treated 4h | 6493.01 | 95 |
GSM687710 | Patient 448 treated 4h | 10250.5 | 97 |
GSM687726 | Patient 451 treated 4h | 15515.9 | 98 |
GSM687730 | Patient 452 treated 4h | 21376.4 | 99 |
GSM687660 | Patient 404 treated 24h | 49200.5 | 99 |
GSM687697 | Patient 441 treated 24h | 36084.8 | 99 |
GSM687709 | Patient 448 treated 24h | 8469.65 | 96 |
GSM687725 | Patient 451 treated 24h | 22235 | 99 |
GSM687729 | Patient 452 treated 24h | 51766.1 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 14502.2 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 9575.3 | 97 |